Aminoguanidine: Approved Phase II/III trial

Alteon Inc. (ALTN) Product: Aminoguanidine Indication: Diabetic nephropathy Status: The FDA approved a final protocol for the company's pivotal Phase II/III trial of aminoguanidine in diabetic nephrop...